Patents
Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
09/2007
09/25/2007US7273869 P-(aminomethyl)phenyl-substituted pyrazoloquinoxalines, imidazoquinoxalines, triazoloquinoxalines and benzoquinoxalines, e.g., N,N-dimethyl-1-[4-(6-phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl)phenyl]methanamine; serine/threonine protein kinase inhibitors for treating cancer
09/20/2007WO2007105154A2 Antibiotic compounds
09/20/2007WO2007105045A1 Novel bis-2-difluoro-pyrrolo[2,1-c][1,4]benzodiazepine dimmers
09/20/2007WO2007104558A1 Thiazoles as nf-kb inhibitors (proteasome inhibitors)
09/20/2007US20070219375 Novel Compound and Organic Electronic Device Using the Same
09/20/2007CA2646516A1 Thiazoles as nf-kb inhibitors (proteasome inhibitors)
09/20/2007CA2645350A1 Novel bis-2-difluoro-pyrrolo[2,1-c][1,4]benzodiazepine dimmers
09/20/2007CA2643962A1 Antibiotic compounds
09/19/2007EP1834954A1 Thiazoles as NF-kB Inhibitors (proteasome inhibitors)
09/19/2007EP1833839A1 Quaternary alkaloid derivatives of chelidonium majus l
09/19/2007CN101037446A Synthesizing method of vinorelbine tartrate
09/19/2007CN100338061C Alkyne-aryl phosphodiesterase-4 inhibitors
09/18/2007US7271176 heterocylic amines such as 2-(5-{3-[4-(4-Chloro-2-methyl-phenyl)-piperazin-1-yl]-propylidene}-5,11-dihydro-10-oxa-1-aza-dibenzo[a,d]cyclohepten-7-yl)-propan-2-ol, used for treating diseases associated with aberrant leukocyte recruitment and/or activation
09/18/2007US7271165 Useful for treating or preventing a variety of antibiotic resistant microbial infections; for example, 25-O-deacetyl-25-(2'',3''-dihydroxypropylcarbonoxy)-5'-[4-isobutyl-1-piperazinyl]benzoxazinorifamycin
09/13/2007US20070213364 Alkoxyphenylpropanoic Acid Derivatives
09/13/2007US20070213342 2-1-Aza-bicyclo[2.2.2]oct-3-yl-6-phenyl-2,3-dihydro-isoindol-1-one, salts and radioactive materials for drug screening; anxiolytic agents; antidepressants; schizophrenia; cognitive activators; attention disorders; Alzheimer's disease; Parkinson's disease; Tourette's syndrome; neuroprotants; analgesics
09/13/2007US20070213334 Cannabinoid receptor ligands and uses thereof
09/12/2007EP1832287A2 The use of anti-histaminics for acute reduction of elevated intracranial pressure
09/12/2007EP1831216A2 Heteroaromatic derivatives useful as anticancer agents
09/12/2007EP1664059B1 Thienopyrroles as antiviral agents
09/12/2007CN101035796A Method of producing a composition, composition and its use
09/12/2007CN100336817C Method of chromatography preparing high purity catharanthine sulphate by continuous medium pressure column
09/11/2007US7268230 Quinazoline compounds
09/11/2007US7268133 Cannabinoid receptor ligands and uses thereof
09/11/2007US7268127 Azaindoles having serotonin receptor affinity
09/07/2007WO2007100670A1 Spiro condensed piperidnes as modulators of muscarinic receptors
09/07/2007CA2642649A1 Modulators of muscarinic receptors
09/06/2007US20070208019 Vasculostatic agents and methods of use thereof
09/06/2007US20070208013 Pyrrolotriazine Derivatives Useful For Treating Hyper-Proliferative Disorders And Diseases Associated With Angiogenesis
09/05/2007EP1828210A1 Chemical compositions for authenticatable polymers and articles, and authentication methods thereof
09/05/2007EP1480032B1 Reagent for determining the absolute configuration of chiral compound and determination method
09/05/2007EP1463733B1 Mitotic kinesin inhibitors
09/05/2007CN100335054C Quinolone carboxylic acid and naphthyridon carboxylic acid derivatives for treatment of helicobacter pylori infections and associated gastroduodenal
09/04/2007US7265378 Light emitting diodes
09/04/2007US7265115 Central nervous system-active cholinergic ligands for neuronal nicotinic receptors; Controlling synaptic transmission; selectively controlling neurotransmitter release; a (halopyridazinyl)-3,8-diazabicyclo(3.2.1)octane
09/04/2007US7265105 Pyrrolobenzodiazepines
09/04/2007US7265104 Tetraazabenzo[e]azulene derivatives and analogs thereof
09/04/2007US7265102 Substituted pyrazoles
08/2007
08/30/2007WO2007097395A1 Fluorine-containing compound and method for producing same, fluorine-containing polymer, organic thin film, and organic thin film device
08/30/2007US20070202574 Novel Saccharothrix Strain an Antibiotics Derived Therefrom, i.e. Mutactimycins and Aldgamycins
08/30/2007CA2642717A1 Treatment of hyperproliferative diseases with vinca alkaloid n-oxide and analogs
08/29/2007EP1558615B1 Purine compounds and use thereof as cannabinoid receptor ligands
08/29/2007CN101027310A Radicals and their use as paramagnetic agents in a dynamic nuclear polarisation process
08/29/2007CN101027303A Imidazo 4,5-dpyrimidines, their uses and methods of preparation
08/29/2007CN101024650A Eremophil-2-internal-ester diploymer having function of inhibiting tumor cell growth activity and use thereof
08/28/2007US7262187 Substituted oxazolo- and thizaolopyrimidinones as a mitotic kinesin inhibitor
08/28/2007US7262186 Kinesin spindle protein inhibitor; antiproliferative agents; anticancer agents; 4-(2,5-difluorophenyl0-N-3-fluoropyrrolidin-3-yl)-2-hydroxymethyl-2-phenyl-2,5-dihydro-1N-pyrrol-1-carboxamide
08/28/2007CA2160243C 36-derivatives of rifamycins and their use as antimicrobial agents
08/23/2007WO2007093873A1 Bis-pyrr0l0[2,l-c] [1, 4] benzodiazepine- anthraquinone conjugates as antitumour agents and a process for the preparation thereof
08/23/2007WO2007093365A2 Novel amino alcohol-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments
08/23/2007US20070197551 such as 3-amino-5,6-dimethyl-2-[3-(4-quinolin-2-ylpiperazin-1-yl)propylthio]-3H-thieno[2,3-d]pyrimidin-4-one, having serotonin receptor modulatory activity, used for treating irritable bowel syndrome
08/23/2007US20070194698 Charge transport compositions and electronic devices made with such compositions
08/23/2007DE19735255B4 Synergistisches Stabilisatorgemisch auf Basis von Polyalkyl-1-oxa-diazaspirodecan-Verbindungen und dessen Verwendung A synergistic stabilizer mixture based on polyalkyl-1-oxa-diazaspirodecan compounds and the use thereof
08/23/2007CA2636879A1 Novel amino alcohol-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments
08/22/2007EP1648904B1 N-sulfonylheterocyclopyrrolylalkylamine compounds as 5-hydroxytryptamine-6 ligands
08/22/2007EP1359908B1 Quinolines and nitrogenated derivatives thereof substituted in 4-position by a piperidine-containing moiety and their use as antibacterial agents
08/16/2007WO2007090887A1 3, 9-diazabicyclo [3.3. 1]nonane derivatives and their use as monoamine?neurotransmitter re-uptake inhibitors
08/16/2007WO2007076086A3 Tricyclic spiro compounds useful as transforming growth factor modulators
08/16/2007US20070191419 (6R,8S)-6-(spiro[isobenzofuran-1-(3H), 4'-piperidin]-1'-ylmethyl)-5,6,7,8-tetrahydroquinolin-8-ol), exhibiting an antagonism to binding of nociceptin to opioid receptor-like-1 receptors, useful as medicines for diseases associated with pain and appetite control or memory and learning
08/16/2007US20070191349 C8, c8' linked 5-oxo-1,2,3,11a-tetrahydro-5h-pyrrolo[2,1-c][1,4] benzodiazepine dimers with 1h-pyrrole-dicarboxylic acid amide linkers and oligomeric analogs therof as well as related compounds for the treatment of proliferative diseases
08/16/2007US20070191309 a 7 or 8-hydroxy; a protected oxygen at position 11; carbamate protecting group at the N10 position (oxycarbonyl); reaction with a diiodoalkane; antitumour anthramycin antibiotic
08/16/2007CA2641683A1 3,9-diazabicyclo[3.3.1]nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
08/15/2007EP1543001B1 Pyrazolopyridine derivatives as tgf beta signal transduction inhibitors for the treatment of cancer
08/15/2007EP1451196B1 The use of substituted tetracyclic imidazole derivatives as anti-histaminics
08/15/2007EP1067933B1 Semi-synthetic ecteinascidins
08/14/2007US7255779 Indolecarboxylic ester trimer and electrochemical cell using the same
08/09/2007WO2007087716A1 Assay for identifying inhibitors of neuronal apoptotic pathways
08/09/2007US20070185157 Tropane derivatives useful in therapy
08/09/2007US20070185131 Heterocyclic Compounds
08/09/2007US20070185120 (4-Methyl-piperazin-1-yl)-(6H-thieno[2,3-b]pyrrol-5-yl)-methanone; (2,3-Dichloro-6H-thieno[2,3-b]pyrrol-5-yl)-(4-methyl-piperazin-1-yl)-methanone; histamine H4 receptor antagonist; treats allergic rhinitis
08/09/2007US20070185087 Compounds and methods for inhibiting mitotic progression
08/09/2007US20070185073 viricides, parasiticide, bactericides, gene therapy and treating cisplatin refractory disease; e.g. 1,1'[[(Propane-1,3-diyl)dioxy]bis(11aS)-11-sulpho-7-methoxy-2-methylidene-1,2,3,10,11,11a-hexahydro-5H-pyrrolo[2,1-c][1,4-benzodiazepin-5-one]] sodium salt
08/09/2007US20070184304 Light-emitter with a light-emitting layer containing a 4-(dicyanomethylene)-2,6-bis(9-[1,1,7,7-tetramethyl-8-alkoxyjulolidyl])-4H-pyran; inferior luminescence properties due to carbonization during vapor deposition; optionally rubrene, 9,10-di(2-naphthyl)anthracene, or 8-hydroxyquinoline aluminum
08/08/2007EP1816127A1 Triazine derivatives for use as selective npy (y5) antagonists
08/08/2007EP1814888A1 Azabenzoxazoles for the treatment of cns disorders
08/08/2007EP1814887A1 Azabenzoxazoles for the treatment of cns disorders
08/08/2007CN1330657C Novel piperidine and piperazine derivatives
08/08/2007CN1330656C Chiral acetal and ketal compounds and their synthesis method and use
08/08/2007CN101014603A Compounds and methods for inhibiting mitotic progression by ingibiting aurora kinase
08/02/2007WO2007076127A3 Condensed imidazoles or pyrazoles and their use as transforming growth factor modulators
08/02/2007US20070179171 Vinca derivatives
08/02/2007US20070179170 Vinorelbine derivatives
08/02/2007US20070179158 2,6-Disubstituted piperiddines as modulators
08/01/2007EP1813616A2 Pyrazoloquinolines with immunomodulating activity
08/01/2007EP1812450A2 Tgf-beta inhibitors
08/01/2007EP1294698B1 Fused azepine derivatives and their use as antidiuretic agents
08/01/2007EP1187592B1 Alpha v integrin receptor antagonists
08/01/2007CN101007816A Improved Biapenem preparation method
08/01/2007CN101007815A Pyrrolehexa-heterocyclic compound and pharmaceutical use thereof
08/01/2007CN101007814A Pyrrolehexa-heterocyclic compound and pharmaceutical use thereof
07/2007
07/31/2007US7250424 Fab I inhibitors
07/31/2007US7250413 C-25 carbamate rifamycin derivatives with activity against drug-resistant microbes
07/26/2007WO2007084073A1 Novel compounds and use thereof
07/26/2007WO2007083638A1 Method for synthesis of ciguatoxin ctx1b and compound useful for the synthesis of ciguatoxin ctx1b
07/26/2007WO2007071393A3 Sulphonamidoaniline derivatives being janus kinases inhibitors
07/26/2007US20070173505 A2a adenosine receptor antagonists
07/26/2007US20070173497 11-Hydroxy-5h-pyrrolo[2,1-c][1,4] benzodiazepin-5-one derivatives as key intermediates for the preparation of c2 substituted pyrrolobenzodiazepines
07/26/2007CA2637417A1 Novel indoloquinoxaline derivatives and their use in the treatment of viral infections
07/26/2007CA2636189A1 Azaindoles useful as inhibitors of janus kinases
07/25/2007EP1809636A1 Synthesis of imidazooxazole and imidazothiazole inhibitors of p38 map kinase
1 ... 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 ... 111